Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseWhole-Body IrradiationBone MarrowBone Marrow CellsAnemia, AplasticBusulfanLeukemiaTransplantation, AutologousHematopoietic Stem Cell TransplantationHistocompatibility TestingLiver TransplantationGraft vs Host ReactionTransplantation ConditioningCyclophosphamideStem CellsGraft SurvivalTransplantation ChimeraKidney TransplantationTissue DonorsStem Cell TransplantationRecurrenceMethotrexateHematopoietic Stem CellsHistocompatibilityCytomegalovirus InfectionsGraft RejectionTransplantation, IsogeneicHeart TransplantationImmunosuppressive AgentsHematologic NeoplasmsBone Marrow PurgingTreatment OutcomeBone and BonesLung TransplantationHematopoiesisImmunosuppressionTransplantation ImmunologyFollow-Up StudiesCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsLymphocyte DepletionLeukemia, Myeloid, AcuteMice, Inbred C57BLOrgan TransplantationRadiation ChimeraBone Marrow DiseasesRemission InductionAcute DiseaseSurvival AnalysisRetrospective StudiesCyclosporineT-LymphocytesHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseCell DifferentiationNuclear FamilyCell TransplantationLeukemia, MyeloidIslets of Langerhans TransplantationLeukocyte TransfusionPancreas TransplantationBone Marrow ExaminationLymphoma, Non-HodgkinCord Blood Stem Cell TransplantationTransplantationPeripheral Blood Stem Cell TransplantationChimeraColony-Forming Units AssayMyelodysplastic SyndromesMesenchymal Stem Cell TransplantationSevere Combined ImmunodeficiencyGraft vs Tumor EffectSurvival RateHematologic DiseasesGraft vs Leukemia EffectBone Marrow NeoplasmsActuarial AnalysisInfectionCells, CulturedAntineoplastic Combined Chemotherapy ProtocolsSkin TransplantationTransplantation ToleranceLiving DonorsEmbryonic Stem CellsLymphocyte TransfusionFlow CytometryCyclosporinsGranulocyte Colony-Stimulating FactorMice, Inbred BALB CAntigens, CD34SpleenMelphalanCarmustineCytarabineMultiple MyelomaAdult Stem Cells